Last update 01 Nov 2024

Invimestrocel (Athersys)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
AMI MultiStem, Allogeneic stem cell therapy - Athersys
+ [3]
Target-
Mechanism
Cell replacements
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2/3
First Approval Date-
RegulationFast Track (US), Regenerative Medicine Advanced Therapy (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ischemic strokePhase 3
JP
15 Nov 2017
Colitis, UlcerativePhase 1
SE
01 Feb 2011
Colitis, UlcerativePhase 1
US
01 Feb 2011
Colitis, UlcerativePhase 1
IT
01 Feb 2011
COVID-19Preclinical
US
28 Apr 2020
Respiratory Distress Syndrome, AcutePreclinical
US
28 Apr 2020
Colitis, UlcerativePreclinical
US
01 Feb 2011
Colitis, UlcerativePreclinical
CA
01 Feb 2011
Colitis, UlcerativePreclinical
SE
01 Feb 2011
Colitis, UlcerativePreclinical
HU
01 Feb 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
206
(sfayxegxoa) = The primary endpoint, Excellent Outcome at 90 days, did not reach statistical significance in this population. gyncnowhle (zsjiofyuit )
Positive
20 May 2022
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free